Juraj Hlavatý

904 total citations
33 papers, 722 citations indexed

About

Juraj Hlavatý is a scholar working on Genetics, Molecular Biology and Genetics. According to data from OpenAlex, Juraj Hlavatý has authored 33 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 17 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Juraj Hlavatý's work include Virus-based gene therapy research (17 papers), CRISPR and Genetic Engineering (7 papers) and RNA Interference and Gene Delivery (5 papers). Juraj Hlavatý is often cited by papers focused on Virus-based gene therapy research (17 papers), CRISPR and Genetic Engineering (7 papers) and RNA Interference and Gene Delivery (5 papers). Juraj Hlavatý collaborates with scholars based in Austria, Slovakia and United States. Juraj Hlavatý's co-authors include Matthias Renner, Walter H. Günzburg, Helga Petznek, Brian Salmons, Ingrid Walter, Reinhard Ertl, Joan M. Robbins, Douglas J. Jolly, Derek Ostertag and Noriyuki Kasahara and has published in prestigious journals such as PLoS ONE, Nature Methods and Journal of Virology.

In The Last Decade

Juraj Hlavatý

33 papers receiving 698 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juraj Hlavatý Austria 13 425 392 226 101 88 33 722
Christopher R. Logg United States 19 630 1.5× 543 1.4× 273 1.2× 60 0.6× 104 1.2× 27 886
Justin C. Roth United States 14 403 0.9× 392 1.0× 394 1.7× 95 0.9× 46 0.5× 25 800
Paul Shabram United States 12 740 1.7× 578 1.5× 322 1.4× 41 0.4× 100 1.1× 21 1.0k
Matthew A. Tyler United States 16 626 1.5× 543 1.4× 450 2.0× 216 2.1× 103 1.2× 29 1.0k
Maria C. Speranza United States 12 463 1.1× 427 1.1× 460 2.0× 113 1.1× 97 1.1× 21 982
Babak Moghimi United States 14 493 1.2× 399 1.0× 474 2.1× 50 0.5× 84 1.0× 23 1.0k
Laura Ahtiainen Finland 15 570 1.3× 279 0.7× 225 1.0× 25 0.2× 68 0.8× 20 881
Beichen Sun Canada 11 264 0.6× 244 0.6× 217 1.0× 93 0.9× 41 0.5× 13 531
Jennifer Coleman United States 11 266 0.6× 447 1.1× 405 1.8× 81 0.8× 45 0.5× 19 677
Stephanie Laufs Germany 22 824 1.9× 574 1.5× 394 1.7× 120 1.2× 41 0.5× 59 1.3k

Countries citing papers authored by Juraj Hlavatý

Since Specialization
Citations

This map shows the geographic impact of Juraj Hlavatý's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juraj Hlavatý with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juraj Hlavatý more than expected).

Fields of papers citing papers by Juraj Hlavatý

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juraj Hlavatý. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juraj Hlavatý. The network helps show where Juraj Hlavatý may publish in the future.

Co-authorship network of co-authors of Juraj Hlavatý

This figure shows the co-authorship network connecting the top 25 collaborators of Juraj Hlavatý. A scholar is included among the top collaborators of Juraj Hlavatý based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juraj Hlavatý. Juraj Hlavatý is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ertl, Reinhard, et al.. (2023). Isolation and Characterization of Novel Canine Osteosarcoma Cell Lines from Chemotherapy-Naïve Patients. Cells. 12(7). 1026–1026. 1 indexed citations
2.
Hlavatý, Juraj, et al.. (2022). Lipid droplet dynamics in healthy and pyometra-affected canine endometrium. BMC Veterinary Research. 18(1). 221–221. 3 indexed citations
3.
Hlavatý, Juraj, et al.. (2022). Lipid droplets and perilipins in canine osteosarcoma. Investigations on tumor tissue, 2D and 3D cell culture models. Veterinary Research Communications. 46(4). 1175–1193. 10 indexed citations
4.
Hlavatý, Juraj, Reinhard Ertl, Barbara C. Rütgen, et al.. (2021). Effect of prednisolone pre-treatment on cat lymphoma cell sensitivity towards chemotherapeutic drugs. Research in Veterinary Science. 138. 178–187. 4 indexed citations
5.
Hlavatý, Juraj, Birgitt Wolfesberger, Marlene Hauck, et al.. (2017). Ezrin and moesin expression in canine and feline osteosarcoma.. PubMed. 32(8). 805–816. 4 indexed citations
6.
Hlavatý, Juraj, Zbyněk Tonar, Matthias Renner, et al.. (2017). Tropism, intracerebral distribution, and transduction efficiency of HIV- and SIV-based lentiviral vectors after injection into the mouse brain: a qualitative and quantitative in vivo study. Histochemistry and Cell Biology. 148(3). 313–329. 3 indexed citations
7.
Hlavatý, Juraj, Yen Y. Tan, Christian F. Singer, et al.. (2017). Expression of ezrin and moesin in primary breast carcinoma and matched lymph node metastases. Clinical & Experimental Metastasis. 34(5). 333–344. 12 indexed citations
8.
9.
Wolfesberger, Birgitt, Andrea Fuchs‐Baumgartinger, Juraj Hlavatý, et al.. (2016). Stem cell growth factor receptor in canine vs. feline osteosarcomas. Oncology Letters. 12(4). 2485–2492. 7 indexed citations
10.
11.
Huang, Tiffany, Juraj Hlavatý, Derek Ostertag, et al.. (2013). Toca 511 gene transfer and 5-fluorocytosine in combination with temozolomide demonstrates synergistic therapeutic efficacy in a temozolomide-sensitive glioblastoma model. Cancer Gene Therapy. 20(10). 544–551. 45 indexed citations
12.
Hlavatý, Juraj, Helga Petznek, Harry Holzmüller, et al.. (2012). Evaluation of a Gene-Directed Enzyme-Product Therapy (GDEPT) in Human Pancreatic Tumor Cells and Their Use as In Vivo Models for Pancreatic Cancer. PLoS ONE. 7(7). e40611–e40611. 11 indexed citations
13.
Ostertag, Derek, Karin Amundson, Ana Paula da Silva, et al.. (2011). Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector. Neuro-Oncology. 14(2). 145–159. 110 indexed citations
14.
Anliker, Brigitte, Tobias Abel, Sabrina Kneissl, et al.. (2010). Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors. Nature Methods. 7(11). 929–935. 116 indexed citations
15.
Hlavatý, Juraj, et al.. (2007). Suicide genes for cancer therapy. Molecular Aspects of Medicine. 28(1). 4–41. 121 indexed citations
16.
Hlavatý, Juraj, Matthias Schittmayer, Anika Stracke, et al.. (2005). Effect of posttranscriptional regulatory elements on transgene expression and virus production in the context of retrovirus vectors. Virology. 341(1). 1–11. 26 indexed citations
17.
Hlavatý, Juraj, et al.. (2004). Effects of sequences of prokaryotic origin on titer and transgene expression in retroviral vectors. Virology. 330(1). 351–360. 12 indexed citations
18.
Hlavatý, Juraj, Anika Stracke, Dieter Klein, et al.. (2004). Multiple Modifications Allow High-Titer Production of Retroviral Vectors Carrying Heterologous Regulatory Elements. Journal of Virology. 78(3). 1384–1392. 21 indexed citations
19.
Hlavatý, Juraj, et al.. (2000). Retrovirus vector containing wild type p53 gene and its effect on human glioma cells.. PubMed. 47(4). 204–11. 2 indexed citations
20.
Hlavatý, Juraj, et al.. (1960). [Adrenal hemorrhage in newborn infants].. PubMed. 15. 880–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher R. Logg Breakdown of academic impact, for papers by Justin C. Roth Breakdown of academic impact, for papers by Paul Shabram Breakdown of academic impact, for papers by Matthew A. Tyler Breakdown of academic impact, for papers by Maria C. Speranza Breakdown of academic impact, for papers by Babak Moghimi Breakdown of academic impact, for papers by Laura Ahtiainen Breakdown of academic impact, for papers by Beichen Sun Breakdown of academic impact, for papers by Jennifer Coleman Breakdown of academic impact, for papers by Stephanie Laufs
Rankless by CCL
2026